Definitive Healthcare (NASDAQ:DH) Stock Price Up 11% – Here’s Why

Shares of Definitive Healthcare Corp. (NASDAQ:DH) were up 11% on Tuesday . The company traded as high as $4.41 and last traded at $4.38. Approximately 105,381 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 826,109 shares. The stock had previously closed at $3.94.

Analyst Ratings Changes

DH has been the subject of a number of research analyst reports. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Thursday, January 16th. Barclays reaffirmed an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a report on Monday, January 13th. Finally, Stephens began coverage on shares of Definitive Healthcare in a research note on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Stock Performance

The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The firm has a market capitalization of $562.60 million, a PE ratio of -1.57, a P/E/G ratio of 3.31 and a beta of 1.41. The company’s fifty day simple moving average is $4.34 and its 200 day simple moving average is $4.47.

Definitive Healthcare (NASDAQ:DH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The business had revenue of $62.70 million for the quarter, compared to analysts’ expectations of $61.66 million. During the same quarter in the previous year, the company posted $0.01 earnings per share. As a group, equities research analysts expect that Definitive Healthcare Corp. will post 0.15 EPS for the current fiscal year.

Insider Activity

In related news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 14.84% of the stock is owned by company insiders.

Institutional Trading of Definitive Healthcare

A number of large investors have recently modified their holdings of the business. Massachusetts Financial Services Co. MA lifted its stake in Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after purchasing an additional 1,626,813 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Definitive Healthcare in the 3rd quarter worth approximately $512,000. State Street Corp boosted its stake in Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock worth $6,257,000 after buying an additional 317,952 shares in the last quarter. Barclays PLC grew its position in Definitive Healthcare by 318.8% during the third quarter. Barclays PLC now owns 81,916 shares of the company’s stock valued at $366,000 after acquiring an additional 62,354 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. raised its stake in shares of Definitive Healthcare by 34.1% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock worth $209,000 after acquiring an additional 12,946 shares in the last quarter. Institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.